Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Completion Placing

12 Feb 2016 17:19

RNS Number : 9963O
FastForward Innovations Limited
12 February 2016
 

12 February 2016

FastForward Innovations Limited

Completion Placing

Admission of New Shares to trading on AIM

Further to its announcements on 28 January and 8 February 2016, the Board of FastForward Innovations Limited ("FastForward" or the "Company") is pleased to announce that it has today completed the placing of 37,426,901 new Ordinary Shares of 1p each (the "Placing Shares") at a price of £0.15 per Placing Share thereby raising US$8,000,000 (£5,614,035 at an exchange rate of £1:US$1.425, being the rate on the date the Company determined the terms of the placing) before expenses (the "Placing").

 

Current Net Asset Value (based on the issued share capital following the Placing)

 

The Company has invested £4.1 million (c. £0.03 per share) into seven investments to date and has, on completion of the Placing, £6.8 million (£0.05 per share) in liquid assets to fund working capital and further investments.

 

Mr. Lorne Abony, the Company's Chief Executive Officer, was pleased to close the Placing in difficult market conditions:

 

"I have had an opportunity to review the current investment portfolio and to work with colleague directors to further develop the Company's future strategy. It is my view, shared by the Board, that the investments made to date have enormous potential for significant shareholder value creation. Beyond this, preliminary analysis indicates that each company is delivering results ahead of their respective business plans and budgets.

 

I intend to provide a comprehensive market update in due course with greater detail around our strategy, specific investment criteria and about our investments and their respective prospects. It is however my goal to work with the Board in the first half of 2016 making opportunistic investments. The second half of 2016 will likely see a heavy emphasis on seeking to crystallize the value of those businesses at valuations well in excess of the value that FFWD acquired its interests; those exits could take the form of investments by third parties at higher valuations, IPO's or sales. I am very comfortable saying that I am truly excited by the management teams we have in place, the milestones that have been achieved, and the results we are seeing, and am very confident that value enhancing events in the near future will reflect positively on our Net Asset Value.

 

The Placing was significantly over subscribed. I appreciate the tremendous confidence shown in me and the rest of the board by new and existing shareholders to deliver them superior returns. Many of our new shareholders are themselves successful technology investors. Their support will further enhance our ability to discover and incubate new tech start ups for the benefit of all our shareholders."

 

Admission of the Placing Shares to AIM

 

The Placing Shares (which will rank pari passu with the existing Ordinary Shares) have been issued and allotted and accordingly, admission to trading on AIM is expected to commence at 8.00 a.m. on 18 February 2016.

 

The enlarged issued share capital of the Company following the issue of the Consideration Shares and the Placing Shares will be 134,108,445 Ordinary Shares with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please visit www.fstfwd.co or contact:

FastForward Innovations Limited Tel: +44 1481 810 100 Elysium Fund Management Limited

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396 James Biddle / Michael Cornish

Peterhouse Corporate Finance Limited (Broker) Tel: +44 (0) 20 7469 0930 Guy Miller / Lucy Williams

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Limited and the companies in which it invests. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMZNZNGVZM
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.